Titre :
  • A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.
Auteur : Delaunoit, Thierry ; Burch, Patrick A ; Reid, Joel M ; Camoriano, John K ; Kobayash, Tomowo ; Braich, Theodore A ; Kaur, Judith S ; Rubin, Joseph ; Erlichman, Charles
Informations sur la publication : Investigational new drugs, 24, 4, (page 327-333)
Statut de publication : Publié, 2006-07
Sujet CREF : Cancérologie
Mots-clés MeSH : Administration, Oral
Adult
Aged
Aged, 80 and over
Antineoplastic Agents -- adverse effects -- chemistry -- pharmacokinetics -- therapeutic use
Arabinonucleosides -- adverse effects -- chemistry -- pharmacokinetics -- therapeutic use
Cytosine -- adverse effects -- analogs & derivatives -- chemistry -- pharmacokinetics -- therapeutic use
Dose-Response Relationship, Drug
Female
Humans
Male
Middle Aged
Neoplasm Staging
Neoplasms -- drug therapy -- pathology
Note : Clinical Trial, Phase I
Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0167-6997 
info:doi/10.1007/s10637-006-5392-0
info:pmid/16502355